nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B3—Docetaxel—head and neck cancer	0.305	0.4	CbGbCtD
Pioglitazone—CYP2D6—Hydroxyurea—head and neck cancer	0.164	0.216	CbGbCtD
Pioglitazone—CYP2C8—Fluorouracil—head and neck cancer	0.0985	0.129	CbGbCtD
Pioglitazone—CYP2C9—Fluorouracil—head and neck cancer	0.0687	0.0901	CbGbCtD
Pioglitazone—CYP2D6—Vinblastine—head and neck cancer	0.0582	0.0763	CbGbCtD
Pioglitazone—CYP3A4—Vinblastine—head and neck cancer	0.037	0.0485	CbGbCtD
Pioglitazone—CYP3A4—Docetaxel—head and neck cancer	0.0305	0.04	CbGbCtD
Pioglitazone—Ischaemia—Vinblastine—head and neck cancer	0.00873	0.0553	CcSEcCtD
Pioglitazone—Developmental delay—Fluorouracil—head and neck cancer	0.0055	0.0348	CcSEcCtD
Pioglitazone—Congenital anomaly—Fluorouracil—head and neck cancer	0.0055	0.0348	CcSEcCtD
Pioglitazone—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00307	0.0194	CcSEcCtD
Pioglitazone—Neoplasm—Vinblastine—head and neck cancer	0.00288	0.0182	CcSEcCtD
Pioglitazone—Neoplasm—Hydroxyurea—head and neck cancer	0.00263	0.0166	CcSEcCtD
Pioglitazone—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0026	0.0165	CcSEcCtD
Pioglitazone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.00259	0.0164	CcSEcCtD
Pioglitazone—Polyp—Docetaxel—head and neck cancer	0.00248	0.0157	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00236	0.0149	CcSEcCtD
Pioglitazone—Hepatic failure—Hydroxyurea—head and neck cancer	0.00235	0.0149	CcSEcCtD
Pioglitazone—Cyst—Docetaxel—head and neck cancer	0.00226	0.0143	CcSEcCtD
Pioglitazone—Liver disorder—Docetaxel—head and neck cancer	0.00221	0.014	CcSEcCtD
Pioglitazone—Angina pectoris—Vinblastine—head and neck cancer	0.00195	0.0123	CcSEcCtD
Pioglitazone—Breast disorder—Hydroxyurea—head and neck cancer	0.00191	0.0121	CcSEcCtD
Pioglitazone—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00188	0.0119	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00176	0.0111	CcSEcCtD
Pioglitazone—Myocardial infarction—Vinblastine—head and neck cancer	0.00175	0.0111	CcSEcCtD
Pioglitazone—Weight increased—Hydroxyurea—head and neck cancer	0.00166	0.0105	CcSEcCtD
Pioglitazone—Infestation—Hydroxyurea—head and neck cancer	0.00163	0.0103	CcSEcCtD
Pioglitazone—Infestation NOS—Hydroxyurea—head and neck cancer	0.00163	0.0103	CcSEcCtD
Pioglitazone—Hypoaesthesia—Vinblastine—head and neck cancer	0.00159	0.0101	CcSEcCtD
Pioglitazone—Pharyngitis—Vinblastine—head and neck cancer	0.00159	0.01	CcSEcCtD
Pioglitazone—Cardiac failure—Fluorouracil—head and neck cancer	0.00156	0.00984	CcSEcCtD
Pioglitazone—Fluid retention—Docetaxel—head and neck cancer	0.00143	0.00907	CcSEcCtD
Pioglitazone—Neoplasm—Docetaxel—head and neck cancer	0.00136	0.00864	CcSEcCtD
Pioglitazone—Pulmonary oedema—Docetaxel—head and neck cancer	0.00134	0.0085	CcSEcCtD
Pioglitazone—Ill-defined disorder—Vinblastine—head and neck cancer	0.00129	0.00818	CcSEcCtD
Pioglitazone—Anaemia—Vinblastine—head and neck cancer	0.00129	0.00815	CcSEcCtD
Pioglitazone—Angina pectoris—Fluorouracil—head and neck cancer	0.00128	0.00809	CcSEcCtD
Pioglitazone—Malaise—Vinblastine—head and neck cancer	0.00126	0.00795	CcSEcCtD
Pioglitazone—Vertigo—Vinblastine—head and neck cancer	0.00125	0.00792	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00122	0.00772	CcSEcCtD
Pioglitazone—Hepatic failure—Docetaxel—head and neck cancer	0.00122	0.00772	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00121	0.00765	CcSEcCtD
Pioglitazone—Hypertension—Vinblastine—head and neck cancer	0.0012	0.00761	CcSEcCtD
Pioglitazone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00118	0.00746	CcSEcCtD
Pioglitazone—Anaemia—Hydroxyurea—head and neck cancer	0.00117	0.00743	CcSEcCtD
Pioglitazone—Discomfort—Vinblastine—head and neck cancer	0.00117	0.00741	CcSEcCtD
Pioglitazone—Infestation NOS—Fluorouracil—head and neck cancer	0.00117	0.0074	CcSEcCtD
Pioglitazone—Infestation—Fluorouracil—head and neck cancer	0.00117	0.0074	CcSEcCtD
Pioglitazone—Visual disturbance—Docetaxel—head and neck cancer	0.00116	0.00732	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00115	0.0073	CcSEcCtD
Pioglitazone—Myocardial infarction—Fluorouracil—head and neck cancer	0.00115	0.00726	CcSEcCtD
Pioglitazone—Malaise—Hydroxyurea—head and neck cancer	0.00115	0.00725	CcSEcCtD
Pioglitazone—Urinary tract infection—Fluorouracil—head and neck cancer	0.00114	0.0072	CcSEcCtD
Pioglitazone—Cardiac failure—Docetaxel—head and neck cancer	0.00112	0.0071	CcSEcCtD
Pioglitazone—Sinusitis—Fluorouracil—head and neck cancer	0.0011	0.00695	CcSEcCtD
Pioglitazone—Pain in extremity—Docetaxel—head and neck cancer	0.0011	0.00693	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00107	0.0068	CcSEcCtD
Pioglitazone—Discomfort—Hydroxyurea—head and neck cancer	0.00107	0.00676	CcSEcCtD
Pioglitazone—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00104	0.00661	CcSEcCtD
Pioglitazone—Pharyngitis—Fluorouracil—head and neck cancer	0.00104	0.0066	CcSEcCtD
Pioglitazone—Oedema—Hydroxyurea—head and neck cancer	0.00104	0.00656	CcSEcCtD
Pioglitazone—Infection—Hydroxyurea—head and neck cancer	0.00103	0.00652	CcSEcCtD
Pioglitazone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00102	0.00643	CcSEcCtD
Pioglitazone—Liver function test abnormal—Docetaxel—head and neck cancer	0.00101	0.0064	CcSEcCtD
Pioglitazone—Skin disorder—Hydroxyurea—head and neck cancer	0.00101	0.00637	CcSEcCtD
Pioglitazone—Abdominal pain upper—Docetaxel—head and neck cancer	0.001	0.00633	CcSEcCtD
Pioglitazone—Breast disorder—Docetaxel—head and neck cancer	0.00099	0.00627	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000966	0.00612	CcSEcCtD
Pioglitazone—Feeling abnormal—Vinblastine—head and neck cancer	0.000937	0.00593	CcSEcCtD
Pioglitazone—Dyspnoea—Hydroxyurea—head and neck cancer	0.000924	0.00585	CcSEcCtD
Pioglitazone—Angina pectoris—Docetaxel—head and neck cancer	0.000922	0.00584	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000895	0.00566	CcSEcCtD
Pioglitazone—Fatigue—Hydroxyurea—head and neck cancer	0.000894	0.00566	CcSEcCtD
Pioglitazone—Weight increased—Docetaxel—head and neck cancer	0.000862	0.00545	CcSEcCtD
Pioglitazone—Weight decreased—Docetaxel—head and neck cancer	0.000857	0.00542	CcSEcCtD
Pioglitazone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000854	0.00541	CcSEcCtD
Pioglitazone—Anaemia—Fluorouracil—head and neck cancer	0.000845	0.00535	CcSEcCtD
Pioglitazone—Infestation NOS—Docetaxel—head and neck cancer	0.000844	0.00534	CcSEcCtD
Pioglitazone—Infestation—Docetaxel—head and neck cancer	0.000844	0.00534	CcSEcCtD
Pioglitazone—Hypersensitivity—Vinblastine—head and neck cancer	0.000837	0.0053	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000832	0.00527	CcSEcCtD
Pioglitazone—Myocardial infarction—Docetaxel—head and neck cancer	0.000828	0.00524	CcSEcCtD
Pioglitazone—Asthenia—Vinblastine—head and neck cancer	0.000815	0.00516	CcSEcCtD
Pioglitazone—Chest pain—Fluorouracil—head and neck cancer	0.000778	0.00493	CcSEcCtD
Pioglitazone—Myalgia—Fluorouracil—head and neck cancer	0.000778	0.00493	CcSEcCtD
Pioglitazone—Diarrhoea—Vinblastine—head and neck cancer	0.000778	0.00492	CcSEcCtD
Pioglitazone—Discomfort—Fluorouracil—head and neck cancer	0.000769	0.00487	CcSEcCtD
Pioglitazone—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000764	0.00483	CcSEcCtD
Pioglitazone—Hepatitis—Docetaxel—head and neck cancer	0.000758	0.0048	CcSEcCtD
Pioglitazone—Hypoaesthesia—Docetaxel—head and neck cancer	0.000754	0.00477	CcSEcCtD
Pioglitazone—Pharyngitis—Docetaxel—head and neck cancer	0.000752	0.00476	CcSEcCtD
Pioglitazone—Dizziness—Vinblastine—head and neck cancer	0.000752	0.00476	CcSEcCtD
Pioglitazone—Urinary tract disorder—Docetaxel—head and neck cancer	0.000749	0.00474	CcSEcCtD
Pioglitazone—Oedema peripheral—Docetaxel—head and neck cancer	0.000747	0.00473	CcSEcCtD
Pioglitazone—Oedema—Fluorouracil—head and neck cancer	0.000746	0.00472	CcSEcCtD
Pioglitazone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000746	0.00472	CcSEcCtD
Pioglitazone—Connective tissue disorder—Docetaxel—head and neck cancer	0.000745	0.00471	CcSEcCtD
Pioglitazone—Asthenia—Hydroxyurea—head and neck cancer	0.000744	0.00471	CcSEcCtD
Pioglitazone—Urethral disorder—Docetaxel—head and neck cancer	0.000743	0.0047	CcSEcCtD
Pioglitazone—Infection—Fluorouracil—head and neck cancer	0.000741	0.00469	CcSEcCtD
Pioglitazone—Nervous system disorder—Fluorouracil—head and neck cancer	0.000732	0.00463	CcSEcCtD
Pioglitazone—Visual impairment—Docetaxel—head and neck cancer	0.00073	0.00462	CcSEcCtD
Pioglitazone—Headache—Vinblastine—head and neck cancer	0.000712	0.00451	CcSEcCtD
Pioglitazone—Diarrhoea—Hydroxyurea—head and neck cancer	0.000709	0.00449	CcSEcCtD
Pioglitazone—Eye disorder—Docetaxel—head and neck cancer	0.000708	0.00448	CcSEcCtD
Pioglitazone—Cardiac disorder—Docetaxel—head and neck cancer	0.000703	0.00445	CcSEcCtD
Pioglitazone—Dizziness—Hydroxyurea—head and neck cancer	0.000685	0.00434	CcSEcCtD
Pioglitazone—Immune system disorder—Docetaxel—head and neck cancer	0.000685	0.00433	CcSEcCtD
Pioglitazone—Mediastinal disorder—Docetaxel—head and neck cancer	0.000683	0.00432	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00068	0.0043	CcSEcCtD
Pioglitazone—Insomnia—Fluorouracil—head and neck cancer	0.000675	0.00427	CcSEcCtD
Pioglitazone—Dyspnoea—Fluorouracil—head and neck cancer	0.000665	0.00421	CcSEcCtD
Pioglitazone—Malnutrition—Docetaxel—head and neck cancer	0.00066	0.00418	CcSEcCtD
Pioglitazone—Headache—Hydroxyurea—head and neck cancer	0.000649	0.00411	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000644	0.00408	CcSEcCtD
Pioglitazone—Back pain—Docetaxel—head and neck cancer	0.000638	0.00404	CcSEcCtD
Pioglitazone—Muscle spasms—Docetaxel—head and neck cancer	0.000634	0.00401	CcSEcCtD
Pioglitazone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000615	0.00389	CcSEcCtD
Pioglitazone—Anaemia—Docetaxel—head and neck cancer	0.00061	0.00386	CcSEcCtD
Pioglitazone—Urticaria—Fluorouracil—head and neck cancer	0.000593	0.00375	CcSEcCtD
Pioglitazone—Hypertension—Docetaxel—head and neck cancer	0.00057	0.00361	CcSEcCtD
Pioglitazone—Arthralgia—Docetaxel—head and neck cancer	0.000562	0.00355	CcSEcCtD
Pioglitazone—Myalgia—Docetaxel—head and neck cancer	0.000562	0.00355	CcSEcCtD
Pioglitazone—Chest pain—Docetaxel—head and neck cancer	0.000562	0.00355	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000558	0.00353	CcSEcCtD
Pioglitazone—Hypersensitivity—Fluorouracil—head and neck cancer	0.00055	0.00348	CcSEcCtD
Pioglitazone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000539	0.00341	CcSEcCtD
Pioglitazone—Oedema—Docetaxel—head and neck cancer	0.000539	0.00341	CcSEcCtD
Pioglitazone—Infection—Docetaxel—head and neck cancer	0.000535	0.00339	CcSEcCtD
Pioglitazone—Nervous system disorder—Docetaxel—head and neck cancer	0.000528	0.00334	CcSEcCtD
Pioglitazone—Skin disorder—Docetaxel—head and neck cancer	0.000523	0.00331	CcSEcCtD
Pioglitazone—Diarrhoea—Fluorouracil—head and neck cancer	0.00051	0.00323	CcSEcCtD
Pioglitazone—Dizziness—Fluorouracil—head and neck cancer	0.000493	0.00312	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000491	0.0031	CcSEcCtD
Pioglitazone—Insomnia—Docetaxel—head and neck cancer	0.000487	0.00308	CcSEcCtD
Pioglitazone—Dyspnoea—Docetaxel—head and neck cancer	0.00048	0.00304	CcSEcCtD
Pioglitazone—Headache—Fluorouracil—head and neck cancer	0.000467	0.00296	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000465	0.00294	CcSEcCtD
Pioglitazone—Fatigue—Docetaxel—head and neck cancer	0.000464	0.00294	CcSEcCtD
Pioglitazone—PTGS1—Biological oxidations—NAT2—head and neck cancer	0.000462	0.00584	CbGpPWpGaD
Pioglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000458	0.00578	CbGpPWpGaD
Pioglitazone—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000457	0.00577	CbGpPWpGaD
Pioglitazone—Feeling abnormal—Docetaxel—head and neck cancer	0.000444	0.00281	CcSEcCtD
Pioglitazone—PPARG—PPARA activates gene expression—CYP1A1—head and neck cancer	0.000442	0.00558	CbGpPWpGaD
Pioglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—head and neck cancer	0.000433	0.00547	CbGpPWpGaD
Pioglitazone—PPARG—Wnt Signaling Pathway Netpath—CCND1—head and neck cancer	0.000432	0.00546	CbGpPWpGaD
Pioglitazone—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00042	0.0053	CbGpPWpGaD
Pioglitazone—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000408	0.00515	CbGpPWpGaD
Pioglitazone—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000404	0.0051	CbGpPWpGaD
Pioglitazone—Hypersensitivity—Docetaxel—head and neck cancer	0.000397	0.00251	CcSEcCtD
Pioglitazone—PTGS1—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000392	0.00495	CbGpPWpGaD
Pioglitazone—Asthenia—Docetaxel—head and neck cancer	0.000386	0.00245	CcSEcCtD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00038	0.0048	CbGpPWpGaD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000376	0.00475	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000374	0.00472	CbGpPWpGaD
Pioglitazone—Diarrhoea—Docetaxel—head and neck cancer	0.000368	0.00233	CcSEcCtD
Pioglitazone—SLCO1B3—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000357	0.00452	CbGpPWpGaD
Pioglitazone—PPARG—Regulation of retinoblastoma protein—CCND1—head and neck cancer	0.000357	0.00452	CbGpPWpGaD
Pioglitazone—Dizziness—Docetaxel—head and neck cancer	0.000356	0.00225	CcSEcCtD
Pioglitazone—PTGS1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000346	0.00437	CbGpPWpGaD
Pioglitazone—PPARG—Wnt Signaling Pathway Netpath—MAPK1—head and neck cancer	0.000339	0.00429	CbGpPWpGaD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000339	0.00428	CbGpPWpGaD
Pioglitazone—Headache—Docetaxel—head and neck cancer	0.000337	0.00213	CcSEcCtD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000335	0.00424	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—CEBPA—head and neck cancer	0.000334	0.00422	CbGpPWpGaD
Pioglitazone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000325	0.0041	CbGpPWpGaD
Pioglitazone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00032	0.00405	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—UROD—head and neck cancer	0.000319	0.00403	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000309	0.0039	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000306	0.00386	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000299	0.00377	CbGpPWpGaD
Pioglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000298	0.00377	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000295	0.00372	CbGpPWpGaD
Pioglitazone—PPARG—Signaling events mediated by HDAC Class I—STAT3—head and neck cancer	0.000294	0.00372	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—TYMS—head and neck cancer	0.000291	0.00368	CbGpPWpGaD
Pioglitazone—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00029	0.00366	CbGpPWpGaD
Pioglitazone—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000286	0.00361	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—RARB—head and neck cancer	0.000276	0.00349	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—UROD—head and neck cancer	0.000272	0.00344	CbGpPWpGaD
Pioglitazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000267	0.00337	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000267	0.00337	CbGpPWpGaD
Pioglitazone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000264	0.00334	CbGpPWpGaD
Pioglitazone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000263	0.00333	CbGpPWpGaD
Pioglitazone—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000263	0.00332	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000263	0.00332	CbGpPWpGaD
Pioglitazone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000261	0.0033	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—YAP1—head and neck cancer	0.000251	0.00317	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000247	0.00312	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000245	0.0031	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.000243	0.00307	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000242	0.00306	CbGpPWpGaD
Pioglitazone—PPARG—Wnt Signaling Pathway Netpath—AKT1—head and neck cancer	0.000241	0.00304	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00024	0.00303	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.00024	0.00303	CbGpPWpGaD
Pioglitazone—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000235	0.00297	CbGpPWpGaD
Pioglitazone—PPARG—SREBP signalling—PIK3CA—head and neck cancer	0.000235	0.00297	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000228	0.00289	CbGpPWpGaD
Pioglitazone—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000223	0.00282	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00022	0.00278	CbGpPWpGaD
Pioglitazone—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000216	0.00274	CbGpPWpGaD
Pioglitazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000216	0.00273	CbGpPWpGaD
Pioglitazone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000216	0.00272	CbGpPWpGaD
Pioglitazone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000214	0.00271	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—UROD—head and neck cancer	0.000214	0.00271	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000211	0.00267	CbGpPWpGaD
Pioglitazone—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000199	0.00252	CbGpPWpGaD
Pioglitazone—PPARG—SREBP signalling—AKT1—head and neck cancer	0.000192	0.00242	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—UROD—head and neck cancer	0.00019	0.00241	CbGpPWpGaD
Pioglitazone—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000182	0.0023	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—STAT3—head and neck cancer	0.000179	0.00227	CbGpPWpGaD
Pioglitazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000174	0.0022	CbGpPWpGaD
Pioglitazone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000172	0.00217	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000166	0.0021	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00016	0.00203	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000158	0.002	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000148	0.00187	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	0.000148	0.00186	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	0.000145	0.00184	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—PTEN—head and neck cancer	0.000142	0.00179	CbGpPWpGaD
Pioglitazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000141	0.00179	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000141	0.00178	CbGpPWpGaD
Pioglitazone—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	0.00014	0.00177	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000139	0.00176	CbGpPWpGaD
Pioglitazone—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000138	0.00174	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—RARB—head and neck cancer	0.000133	0.00168	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—NAT2—head and neck cancer	0.000132	0.00167	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000132	0.00166	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.00013	0.00164	CbGpPWpGaD
Pioglitazone—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000125	0.00158	CbGpPWpGaD
Pioglitazone—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000123	0.00156	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—UROD—head and neck cancer	0.000123	0.00155	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	0.000121	0.00153	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—YAP1—head and neck cancer	0.000121	0.00153	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.00012	0.00152	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00012	0.00152	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	0.000119	0.00151	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000119	0.0015	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000118	0.0015	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—DPYD—head and neck cancer	0.000116	0.00147	CbGpPWpGaD
Pioglitazone—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	0.000115	0.00145	CbGpPWpGaD
Pioglitazone—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000114	0.00144	CbGpPWpGaD
Pioglitazone—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000113	0.00143	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000113	0.00143	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—NAT2—head and neck cancer	0.000113	0.00143	CbGpPWpGaD
Pioglitazone—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000112	0.00142	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—YAP1—head and neck cancer	0.00011	0.00139	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—UROD—head and neck cancer	0.00011	0.00139	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—NOTCH1—head and neck cancer	0.000106	0.00135	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—UROD—head and neck cancer	0.000101	0.00128	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—UROD—head and neck cancer	0.0001	0.00127	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—DPYD—head and neck cancer	9.9e-05	0.00125	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—TP53—head and neck cancer	9.66e-05	0.00122	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.54e-05	0.00121	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.44e-05	0.00119	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—YAP1—head and neck cancer	9.39e-05	0.00119	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.35e-05	0.00118	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—NAT2—head and neck cancer	8.89e-05	0.00112	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.52e-05	0.00108	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.4e-05	0.00106	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.31e-05	0.00105	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.27e-05	0.00105	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	7.92e-05	0.001	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NAT2—head and neck cancer	7.91e-05	0.000999	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	7.81e-05	0.000987	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—DPYD—head and neck cancer	7.79e-05	0.000985	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.77e-05	0.000982	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	7.51e-05	0.000949	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	7.4e-05	0.000936	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—YAP1—head and neck cancer	7.4e-05	0.000935	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.21e-05	0.000912	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.06e-05	0.000892	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—DPYD—head and neck cancer	6.93e-05	0.000876	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—TYMS—head and neck cancer	6.61e-05	0.000835	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—UROD—head and neck cancer	6.6e-05	0.000834	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—YAP1—head and neck cancer	6.58e-05	0.000832	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GSTM1—head and neck cancer	6.53e-05	0.000826	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—GPX1—head and neck cancer	6.26e-05	0.000791	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—VEGFA—head and neck cancer	6.22e-05	0.000787	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP1A1—head and neck cancer	6.19e-05	0.000783	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—STAT3—head and neck cancer	6.16e-05	0.000779	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.15e-05	0.000778	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK3—head and neck cancer	5.89e-05	0.000744	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—TYMS—head and neck cancer	5.64e-05	0.000713	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK1—head and neck cancer	5.6e-05	0.000708	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—EGFR—head and neck cancer	5.6e-05	0.000708	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GSTM1—head and neck cancer	5.58e-05	0.000705	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.56e-05	0.000702	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—NOTCH1—head and neck cancer	5.44e-05	0.000688	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.42e-05	0.000686	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.37e-05	0.000679	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—GPX1—head and neck cancer	5.34e-05	0.000675	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP1A1—head and neck cancer	5.29e-05	0.000668	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NAT2—head and neck cancer	5.11e-05	0.000645	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.09e-05	0.000643	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.94e-05	0.000625	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.85e-05	0.000612	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.84e-05	0.000612	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.79e-05	0.000606	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NAT2—head and neck cancer	4.56e-05	0.000576	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—HRAS—head and neck cancer	4.5e-05	0.000568	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—DPYD—head and neck cancer	4.48e-05	0.000566	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—TYMS—head and neck cancer	4.44e-05	0.000561	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.41e-05	0.000558	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GSTM1—head and neck cancer	4.39e-05	0.000555	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.37e-05	0.000552	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.34e-05	0.000549	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.31e-05	0.000545	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—YAP1—head and neck cancer	4.25e-05	0.000537	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—GPX1—head and neck cancer	4.2e-05	0.000531	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NAT2—head and neck cancer	4.19e-05	0.00053	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	4.16e-05	0.000526	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NAT2—head and neck cancer	4.16e-05	0.000525	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—DPYD—head and neck cancer	4e-05	0.000505	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—AKT1—head and neck cancer	3.97e-05	0.000502	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—TYMS—head and neck cancer	3.95e-05	0.000499	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTM1—head and neck cancer	3.91e-05	0.000494	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—YAP1—head and neck cancer	3.79e-05	0.000479	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GPX1—head and neck cancer	3.74e-05	0.000473	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1A1—head and neck cancer	3.7e-05	0.000468	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTGS2—head and neck cancer	3.68e-05	0.000466	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—DPYD—head and neck cancer	3.68e-05	0.000465	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—DPYD—head and neck cancer	3.65e-05	0.000461	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—YAP1—head and neck cancer	3.49e-05	0.000441	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—YAP1—head and neck cancer	3.46e-05	0.000437	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.42e-05	0.000432	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—head and neck cancer	3.21e-05	0.000406	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.19e-05	0.000404	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTGS2—head and neck cancer	3.14e-05	0.000397	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.04e-05	0.000384	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAPK3—head and neck cancer	3.01e-05	0.000381	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.85e-05	0.00036	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.79e-05	0.000352	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NAT2—head and neck cancer	2.74e-05	0.000346	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—head and neck cancer	2.74e-05	0.000346	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.6e-05	0.000328	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TYMS—head and neck cancer	2.55e-05	0.000323	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.52e-05	0.000319	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.49e-05	0.000314	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTGS2—head and neck cancer	2.48e-05	0.000313	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GPX1—head and neck cancer	2.42e-05	0.000305	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—DPYD—head and neck cancer	2.4e-05	0.000304	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2.39e-05	0.000302	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—YAP1—head and neck cancer	2.28e-05	0.000288	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TYMS—head and neck cancer	2.28e-05	0.000288	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.27e-05	0.000286	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—head and neck cancer	2.27e-05	0.000286	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.25e-05	0.000285	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTGS2—head and neck cancer	2.2e-05	0.000278	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—head and neck cancer	2.16e-05	0.000273	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GPX1—head and neck cancer	2.16e-05	0.000273	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.13e-05	0.00027	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TYMS—head and neck cancer	2.1e-05	0.000265	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TYMS—head and neck cancer	2.08e-05	0.000262	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.07e-05	0.000262	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.05e-05	0.000259	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—head and neck cancer	2.03e-05	0.000257	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GPX1—head and neck cancer	1.98e-05	0.000251	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GPX1—head and neck cancer	1.97e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.96e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.96e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.95e-05	0.000246	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—head and neck cancer	1.93e-05	0.000244	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—head and neck cancer	1.92e-05	0.000243	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—head and neck cancer	1.85e-05	0.000234	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.75e-05	0.000222	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.6e-05	0.000202	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—head and neck cancer	1.58e-05	0.0002	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	1.52e-05	0.000192	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.42e-05	0.00018	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.37e-05	0.000173	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.35e-05	0.000171	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.35e-05	0.000171	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GPX1—head and neck cancer	1.3e-05	0.000164	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.28e-05	0.000162	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.27e-05	0.00016	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—head and neck cancer	1.24e-05	0.000157	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—head and neck cancer	1.24e-05	0.000157	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.17e-05	0.000148	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.16e-05	0.000146	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—head and neck cancer	1.11e-05	0.00014	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—head and neck cancer	1.11e-05	0.00014	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—head and neck cancer	1.02e-05	0.000129	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—head and neck cancer	1.01e-05	0.000128	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—head and neck cancer	8.75e-06	0.000111	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—head and neck cancer	7.81e-06	9.87e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.63e-06	9.65e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—head and neck cancer	7.18e-06	9.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—head and neck cancer	7.15e-06	9.03e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.12e-06	9e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—head and neck cancer	6.66e-06	8.41e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—head and neck cancer	6.38e-06	8.06e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—head and neck cancer	5.87e-06	7.42e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—head and neck cancer	5.82e-06	7.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.7e-06	5.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—head and neck cancer	3.84e-06	4.85e-05	CbGpPWpGaD
